Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | SNCA | P37840 | 2/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | STIM1 | Q13586 | 4/20 | 0.44 |
| ▸ | ORAI1 | Q96D31 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23430898 | 0.88 | SNCA (0.54) | MAPTSNCACYP1B1STIM1ORAI1 | |
| SCHEMBL28936942 | 0.76 | SQSTM1 (0.68) | STIM1ORAI1 | |
| SCHEMBL20533137 | 0.76 | ABCG2 (0.41) | ABCG2 | |
| SCHEMBL23405475 | 0.75 | MAPT (0.67) | MAPTSNCACYP1B1STIM1ORAI1 | |
| SCHEMBL23879983 | 0.74 | CA1 (0.47) | MEN1LMNATSHRMAPK1KMT2A | |
| SCHEMBL23405471 | 0.74 | SNCA (0.62) | MAPTSNCAKDM4EMEN1ALDH1A1 | |
| SCHEMBL20533640 | 0.73 | SCN2A (0.43) | — | |
| SCHEMBL23405493 | 0.72 | SNCA (0.59) | MAPTSNCAKDM4EMEN1ALDH1A1 | |
| SCHEMBL12682333 | 0.71 | SNCA (1.00) | MAPTSNCACYP1B1PTGS2CA1 | |
| SCHEMBL23405500 | 0.70 | SNCA (0.61) | MAPTSNCAMEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12297178-B2 | Triazole derivative and use thereof | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2025-05-13 | — | — | US | claimed |
| US-20240166611-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2024-05-23 | — | — | US | claimed |
| US-20210163425-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2021-06-03 | — | — | US | claimed |
| US-12297178-B2 | Triazole derivative and use thereof | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2025-05-13 | — | — | US | disclosed |
| US-20240166611-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2024-05-23 | — | — | US | disclosed |
| US-20210163425-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2021-06-03 | — | — | US | disclosed |
| US-20210163425-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163425-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | FABP4, LIPC, GPR119 | MAPT 2951/4885SNCA 4775/4885CYP1B1 754/4885 |
| US-12297178-B2 | Triazole derivative and use thereof | FABP4, LIPC, GPR119 | MAPT 2945/4885SNCA 4771/4885CYP1B1 771/4885 |
| US-20240166611-A1 | TRIAZOLE DERIVATIVE AND USE THEREOF | FABP4, LIPC, GPR119 | MAPT 2945/4885SNCA 4771/4885CYP1B1 771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.